LIN JINSHENG's Third-Party Allotment Boosts Stake to 46.03%... Massive Dilution and Control Consolidation


  • LIN JINSHENG, the largest shareholder of CXI, acquired 3,700,000 new shares at 1,955 KRW per share via a third-party allotment, increasing his stake from 22.17% to 46.03%.
  • The issuance raised total shares from 7,469,660 to 11,169,660, diluting existing shareholders by approximately 49.5%. The acquisition was funded with 7.3 billion KRW of self-financing from dividends and investment income.
  • The reported purpose is to influence management, but no specific operational plans were disclosed, which may negatively impact near-term stock sentiment. No buyback or cancellation of treasury shares was reported.
  • [AI Summary]Largest shareholder LIN JINSHENG significantly strengthened control by raising his stake to 46.03% through a third-party allotment, but existing shareholders face massive dilution. The capital deployment lacks clear growth-oriented objectives, focusing on control consolidation, which poses a risk to short-term share price performance.

KOSDAQ Filing Information


  • Report on Large Shareholding (General)
  • Company: CXI Healthcare Technology Group (900120)
  • Submission: LIN JINSHENG

  • Shares: 37,348,303
  • Price: 391 KRW
  • Market Cap: 14.6 B KRW